Guardant Health (GH) Operating Leases (2019 - 2026)
Guardant Health's Operating Leases history spans 7 years, with the latest figure at $206.1 million for Q4 2025.
- On a quarterly basis, Operating Leases rose 25.47% to $206.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $206.1 million, a 25.47% increase, with the full-year FY2025 number at $206.1 million, up 25.47% from a year prior.
- Operating Leases hit $206.1 million in Q4 2025 for Guardant Health, down from $211.8 million in the prior quarter.
- Over the last five years, Operating Leases for GH hit a ceiling of $240.8 million in Q2 2022 and a floor of $164.3 million in Q4 2024.
- Historically, Operating Leases has averaged $205.4 million across 5 years, with a median of $210.9 million in 2022.
- Biggest five-year swings in Operating Leases: surged 543.48% in 2021 and later fell 22.76% in 2024.
- Tracing GH's Operating Leases over 5 years: stood at $226.1 million in 2021, then decreased by 7.09% to $210.0 million in 2022, then dropped by 11.51% to $185.8 million in 2023, then decreased by 11.6% to $164.3 million in 2024, then rose by 25.47% to $206.1 million in 2025.
- Business Quant data shows Operating Leases for GH at $206.1 million in Q4 2025, $211.8 million in Q3 2025, and $192.3 million in Q2 2025.